Our findings indicated that aFGF ameliorates demyelination and upregulates myelin-related proteins and genes in chronic T2DM, and these effects were likely regulated by facilitating SC proliferation and migration and inhibiting its apoptosis. Here, FGF1 is linked to type 2 diabetes mellitus.